Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Innovative DNA technology speeds up TB diagnosis
DNA
Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

Whole Genome Sequencing found to be more effective

Scientists are using innovative DNA technology to diagnose cases of TB up to eight times faster than traditional methods.

A study led by the University of Oxford concludes that Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

The researchers say that the method marks 'a significant milestone' in the way TB is tackled, but the outlook looks even better, as whole genome sequencing technology is set to improve.

Whole Genome Sequencing has been used before in TB research studies, but this is the first time that it has been applied in real world scenarios.

In the study, the researchers were able to detect presence of TB and whether it was resistant to commonly used antibiotics within one week - up to eight times faster than utilising traditional diagnosis methods. 

Furthermore, the fast diagnosis meant the scientists were able to detect and respond to potential outbreaks as they happen.

The method has also proven to be more cost-effective, at an average of £481 per positive case, compared to £517 per case using current technologies.

Lead author Dr Louise Pankhurst from the University of Oxford, said: "This is a really exciting time to be working in infectious disease research. The UK is poised to become the first country in the world to replace traditional tuberculosis diagnosis with whole genome sequencing.

"Our study has shown how this will dramatically speed up the time taken to diagnose TB, helping patients be placed on the most effective treatment as soon as possible and reducing the risk of disease transmission."

The research, Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study is published in the Lancet Respiratory Medicine.

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.